Minax XL

Country: New Zealand

Lingwa: Ingliż

Sors: Medsafe (Medicines Safety Authority)

Ingredjent attiv:

Metoprolol succinate 23.75mg

Disponibbli minn:

Viatris Limited

INN (Isem Internazzjonali):

Metoprolol succinate 23.75 mg

Dożaġġ:

23.75 mg

Għamla farmaċewtika:

Modified release tablet

Kompożizzjoni:

Active: Metoprolol succinate 23.75mg Excipient: Colloidal silicon dioxide Ethylcellulose Hypromellose Macrogol 400 Macrogol 6000 Microcrystalline cellulose Opadry white 32K58900 Purified water Sodium stearyl fumarate

Tip ta 'preskrizzjoni:

Prescription

Manifatturat minn:

CTX Life Sciences Pvt. Limited

Indikazzjonijiet terapewtiċi:

· Hypertension. To reduce blood pressure and to reduce the risk of cardiovascular and coronary mortality (including sudden death), and morbidity. · Paediatric hypertension.

Sommarju tal-prodott:

Package - Contents - Shelf Life: Blister pack, OPA/Al/PVC/Al or PVC/Aclar/Al - 15 tablets - 24 months from date of manufacture stored at or below 25°C - Blister pack, OPA/Al/PVC/Al or PVC/Aclar/Al - 30 tablets - 24 months from date of manufacture stored at or below 25°C - Bottle, plastic, HDPE with PP screw cap and desiccant - 30 tablets - 24 months from date of manufacture stored at or below 25°C - Bottle, plastic, HDPE with PP screw cap and desiccant - 500 tablets - 24 months from date of manufacture stored at or below 25°C

Data ta 'l-awtorizzazzjoni:

2013-01-07